Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Chemotherapy drug effective at preventing breast cancer's return, gives patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.

7 Jun 2017

Anti-nausea drug may be new treatment for obstructive sleep apnea

An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

6 Jun 2017

Symptom self-reporting web-based tool could be used to help extend oncology patients' lives, study finds

The study funded by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) has found that a simple intervention such as a web-based tool that facilitates patients to report their symptoms in real time, triggering alerts to clinicians, can have major benefits such as longer survival.

5 Jun 2017

Cancer treatment may be effective therapy for psoriasis

HDAC inhibitors, already widely used to treat cancer, may be an effective therapy for psoriasis as well, scientists report.

31 May 2017

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

31 May 2017

Researchers make significant advance in treatment of bowel cancer

New research led by Queen's University Belfast has discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.

31 May 2017

Many cancer patients' ED visits could be avoided with better symptom management, timely care

As many as 53 percent of cancer patients' Emergency Department visits that do not require admission could be avoided with better symptom management and greater availability of outpatient care tailored to their needs, according to a new study from Fred Hutchinson Cancer Research Center.

31 May 2017

First generic version of drug to treat ADHD receives FDA approval

The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.

30 May 2017

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.

27 May 2017

Study aims to find if IV acetaminophen can lead to lower doses of opioids after hip replacement surgery

When considering joint replacement, many patients worry about how much pain they'll experience after surgery. It's a valid concern. Pain control is important not only to avoid discomfort.

26 May 2017

Clinical study tests 100-year-old drug in children with autism spectrum disorder

In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.

26 May 2017

Cluster headaches: searching for effective therapies

Cluster headaches are probably the most painful types of pain a human can suffer and it is for no small reason that this condition is also sometimes referred to as suicide headache.

25 May 2017

FDA grants accelerated approval to cancer treatment based on common biomarker

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

23 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

Targeted therapy appears to be more effective in preventing lung cancer recurrence

The targeted therapy gefitinib appears more effective in preventing recurrence after lung cancer surgery than the standard of care, chemotherapy.

18 May 2017

Solid or tube feeding early in pancreatitis may help reduce hospital stays, research finds

When the excruciating pain of a pancreas attack sends someone to the hospital, eating is probably the last thing they're thinking of. And for decades, medical teams have kept such patients away from solid food for days.

16 May 2017

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.

12 May 2017

Nausea News and Research

Further Reading

Chemotherapy drug effective at preventing breast cancer's return, gives patients a better quality of life

Anti-nausea drug may be new treatment for obstructive sleep apnea

Symptom self-reporting web-based tool could be used to help extend oncology patients' lives, study finds

Cancer treatment may be effective therapy for psoriasis

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Researchers make significant advance in treatment of bowel cancer

Many cancer patients' ED visits could be avoided with better symptom management, timely care

First generic version of drug to treat ADHD receives FDA approval

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Study aims to find if IV acetaminophen can lead to lower doses of opioids after hip replacement surgery

Clinical study tests 100-year-old drug in children with autism spectrum disorder

Cluster headaches: searching for effective therapies

FDA grants accelerated approval to cancer treatment based on common biomarker

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

Targeted therapy appears to be more effective in preventing lung cancer recurrence

Solid or tube feeding early in pancreatitis may help reduce hospital stays, research finds

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

Anisakiasis seen in patients in western countries as popularity of raw fish and seafood dishes increases

FDA approves new AML drug after clinical testing at Dana-Farber

Breakthrough therapy reduces symptoms of Graves' eye disease in clinical trials

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News